Omeros Corporation OMER
NASDAQ · United States · Health Technology
$18.97-0.07 (-0.37%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | 0.15 | -0.27 | +155.9% | $28.53M | +124.8% | +27.6%$13.60→$17.35 |
| Q1 2026 | 2026-05-13 | 0.57 | -0.39 | +246.2% | — | — | -10.0%$14.76→$13.28 |
| Q4 2025 | 2026-03-31 | 0.98 | 0.17 | +476.5% | — | — | +23.1%$9.81→$12.08 |
| Q3 2025 | 2025-11-13 | -0.32 | -0.48 | +33.3% | — | — | +14.2%$6.89→$7.87 |
| Q2 2025 | 2025-08-14 | -0.53 | -0.55 | +3.6% | — | — | — |
| Q1 2025 | 2025-05-15 | -0.65 | -0.60 | -8.3% | — | — | — |
| Q4 2024 | 2025-03-31 | -0.55 | -0.71 | +22.5% | — | — | — |
| Q3 2024 | 2024-11-13 | -0.64 | -0.77 | +16.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.